Dr. Jo Varshney is the Founder and CEO of VeriSIM Life, and President and CEO of PulmoSIM Therapeutics, a subsidiary of VeriSIM Life. She is a visionary in the fields of deep technology and preclinical drug discovery and development. Dr. Varshney is the inventor of VeriSIM Life’s BIOiSIM core technology—a unified framework combining chemical and biological modeling along with AI and ML techniques and data to help clients optimize portfolio management and increase their assets’ clinical success. Additionally, she manages the drug assets being developed in PulmoSIM.
A drug development approach that makes use of hybrid AI can de-risk drug development while simultaneously removing other barriers to success. In other words, it has the power to significantly reduce the drug development timeline, and ultimately, save more lives.